AGLE NASDAQ
Aeglea BioTherapeutics, Inc.
1W: +22.1%
1M: +74.8%
3M: +70.3%
1Y: +117.3%
3Y: -91.1%
5Y: -88.1%
$12.01
Last traded 2023-12-26 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+100.0% YoY
$-179M
Net Income
-115.8% YoY
$-209M
Free Cash Flow
-1.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-23.0%
ROA-20.9%
ROIC359.8%
Valuation
P/E-6.0
P/B0.9
EV/EBITDA-3.1
Leverage
Debt/Equity0.00
Current Ratio18.53
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z13.01
Beneish M0.00